Adaptive Biotechnologies Corp (ADPT)
3.60
-0.12
(-3.23%)
USD |
NASDAQ |
May 20, 16:00
3.60
0.00 (0.00%)
After-Hours: 20:00
Adaptive Biotechnologies Enterprise Value: 222.98M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 222.98M |
| May 16, 2024 | 239.19M |
| May 15, 2024 | 265.72M |
| May 14, 2024 | 274.56M |
| May 13, 2024 | 250.98M |
| May 10, 2024 | 206.77M |
| May 09, 2024 | 215.61M |
| May 08, 2024 | 159.61M |
| May 07, 2024 | 149.30M |
| May 06, 2024 | 165.51M |
| May 03, 2024 | 134.56M |
| May 02, 2024 | 122.77M |
| May 01, 2024 | 102.14M |
| April 30, 2024 | 77.09M |
| April 29, 2024 | 96.24M |
| April 26, 2024 | 74.14M |
| April 25, 2024 | 75.61M |
| April 24, 2024 | 74.14M |
| April 23, 2024 | 71.19M |
| April 22, 2024 | 60.88M |
| April 19, 2024 | 44.66M |
| April 18, 2024 | 35.09M |
| April 17, 2024 | 50.56M |
| April 16, 2024 | 96.24M |
| April 15, 2024 | 119.82M |
| Date | Value |
|---|---|
| April 12, 2024 | 134.56M |
| April 11, 2024 | 77.09M |
| April 10, 2024 | 84.45M |
| April 09, 2024 | 122.77M |
| April 08, 2024 | 108.03M |
| April 05, 2024 | 71.19M |
| April 04, 2024 | 93.30M |
| April 03, 2024 | 85.93M |
| April 02, 2024 | 130.14M |
| April 01, 2024 | 149.30M |
| March 31, 2024 | 164.03M |
| March 28, 2024 | 119.22M |
| March 27, 2024 | 72.79M |
| March 26, 2024 | 71.34M |
| March 25, 2024 | 106.17M |
| March 22, 2024 | 123.58M |
| March 21, 2024 | 136.64M |
| March 20, 2024 | 143.89M |
| March 19, 2024 | 127.93M |
| March 18, 2024 | 114.87M |
| March 15, 2024 | 123.58M |
| March 14, 2024 | 126.48M |
| March 13, 2024 | 148.24M |
| March 12, 2024 | 174.36M |
| March 11, 2024 | 201.93M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
35.09M
Minimum
Apr 18 2024
8.636B
Maximum
Jan 22 2021
2.703B
Average
2.684B
Median
Oct 29 2019
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 5.156M |
| Palatin Technologies Inc | 22.26M |
| iBio Inc | 16.77M |
| Theriva Biologics Inc | -8.901M |
| Oragenics Inc | 8.862M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -47.51M |
| Revenue (Quarterly) | 41.87M |
| Total Expenses (Quarterly) | 90.64M |
| EPS Diluted (Quarterly) | -0.33 |
| Gross Profit Margin (Quarterly) | 56.89% |
| Profit Margin (Quarterly) | -113.5% |
| Earnings Yield | -41.39% |
| Normalized Earnings Yield | -41.39 |